{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to UT MD Anderson
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

UT MD Anderson workforce members:  Select " UT MD ANDERSON LOGIN" and enter your UT MD Anderson email address and password.

Guests (all other than UT MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

UT MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

A Comprehensive Board Review in Hematology and Medical Oncology


LIVEHematologyMedical OncologyBoard Review
A Comprehensive Board Review in Hematology and Medical Oncology Banner

  • Overview
  • Faculty
Add to Calendar A Comprehensive Board Review in Hematology and Medical Oncology 9/27/2021 7:15:00 AM 10/2/2021 5:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/hmobr2021 Description: The course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies. Online false MM/DD/YYYY


Date & Location
Monday, September 27, 2021, 7:15 AM - Saturday, October 2, 2021, 5:00 PM, Online

Target Audience
Specialties - Geriatric Medicine
Professions - Physician (MD or DO)

Credits
AMA PRA Category 1 Credits™ (50.75 hours), ABIM MOC Part 2 (50.75 hours), Non-Physician Attendance (50.75 hours)

Overview
The course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty.
  2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
  3. Demonstrate proficiency of knowledge in hematology and medical oncology.
  4. Incorporate recent advances in management of hematologic and oncologic patients.
  5. Define molecular determinants of cancer risk and apply this knowledge in practice.

Registration

A Virtual Live Streaming Course

The Comprehensive Board Review in Hematology and Medical Oncology is going virtual. This program will be presented only as a live streaming course. You will receive an email from the course platform to log in and access the live course online approximately a week before the conference.

COMPREHENSIVE PROGRAM MATERIAL AVAILABLE FOR NON-ATTENDEES

CME Credits and MOC Points are awarded only by attending the virtual course.

For more information to purchase course material click here.

PRESENTATIONS:

Course syllabus will not be printed. Presentations (slides) will be available online via the course platform and Canvas. The PowerPoint presentations will be posted online as PDFs prior to the conference. You will receive an invitation email with directives to log in Canvas.

  • The Full Conference and Hematology Session will begin at 7:30 am on Monday, September 27. The Hematology Session will adjourn at 4:30 pm on Wednesday, September 29. The full conference will adjourn at 4:55 pm on Saturday, October 2.
  • The Oncology Session will begin at 12:30 pm on Tuesday, September 28 and adjourn at 4:55 pm on Saturday, October 2.

Advanced registration is encouraged. Please see the registration fees below.

*NOTE: The conference registration fee includes the tuition, access to course virtual platform with PDFs of the slides and Canvas - online web-based system with recorded videos.

The deadline for advanced registration is Friday, September 3, 2021.

Telephone registrations are not accepted.

We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)
  • Check (payable through U.S. banks only)
  • Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

CONFERENCE REGISTRATION FEES

Full Conference - MDs, PhDs, DOs, PharmDs

Postmarked On Or Before August 6, 2021 - $1,200
Postmarked On Or Before September 3, 2021 - $1,300
Postmarked After September 3, 2021 - $1,400

Full Conference - Residents/Fellows/MD Anderson Alumni*

Postmarked On Or Before August 6, 2021 - $800
Postmarked On Or Before September 3, 2021 - $900
Postmarked After September 3, 2021 - $1,000
 
* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee. 

Full Conference

Providers/Nurses/Advanced Practice Nurses* - $450
 

Full Conference

MD Anderson/Baylor Faculty/Staff - $500
MD Anderson/Baylor Clinical Fellows* - Exempt
 
* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee. 

Hematology Session - 3 days (Monday - Wednesday) -  MDs, PhDs, DOs, PharmDs

Postmarked On Or Before August 6, 2021 - $550
Postmarked On Or Before September 3, 2021 - $600
Postmarked After September 3, 2021 - $650

Hematology Session - 3 days (Monday - Wednesday) - Residents/Fellows/MD Anderson Alumni*
 
Postmarked On Or Before August 6, 2021 - $350
Postmarked On Or Before September 3, 2021 - $400
Postmarked After September 3, 2021 - $450

* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee.


Oncology Session - 4 1/2 days (Tuesday PM - Saturday) -  MDs, PhDs, DOs, PharmDs
Postmarked On Or Before August 6, 2021 - $650
Postmarked On Or Before September 3, 2021 - $700
Postmarked After September 3, 2021 - $750
 
Oncology Session - 4 1/2 days (Tuesday PM  - Saturday) - Residents/Fellows/MD Anderson Alumni*
 
Postmarked On Or Before August 6, 2021 - $450
Postmarked On Or Before September 3, 2021 - $500
Postmarked After September 3, 2021 - $550
 
* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee.

REFUND/CANCELLATION POLICY

The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Friday, September 3, 2021.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee. Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. Please check the website.

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Chairs for consideration.

SPECIAL ASSISTANCE
Contact Felisha Estelle in Continuing Professional Education at 713-745-0083 or 1-866-531-MOBR (6627) if you have any ADA accommodation needs. 

Accreditation
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 50.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 50.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.
 
Please Note: The deadline to claim MOC Points and CME Credits is November 2, 2021.
 

 

 




Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 


The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Suresh K. Reddy, MD
Professor
University of Texas MD Anderson Cancer Center
CE Reviewer
Nothing to disclose
Sharon H. Giordano, MD, FASCO
Professor
The University of Texas MD Anderson Cancer Center
Co-Director, Faculty
Nothing to disclose
Tapan M. Kadia, MD
Professor
The University of Texas MD Anderson Cancer Center
Co-Director, Faculty
Grant or research support-Bristol-Myers Squibb|Grant or research support-Pfizer, Inc.|Grant or research support-Other-Abbvie|Grant or research support-Other-Amgen|Grant or research support-Genentech, Inc.|Grant or research support-Other-Ascentage|Grant or research support-Other-Cellenkos|Grant or research support-AstraZeneca|Grant or research support-Other-Astellas|Paid consultant-Other-Abbvie|Paid consultant-Genentech, Inc.|Grant or research support-Other-Jazz|Paid consultant-Other-Jazz|Paid consultant-Novartis AG|Paid consultant-Daiichi Sankyo|Paid consultant-Other-Agios|Paid consultant-Pfizer, Inc.
Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine
Co-Director, Faculty
Stocks or stock options, excluding diversified mutual funds-Biogen Idec-|Grant or research support-Incyte-|Stocks or stock options, excluding diversified mutual funds-Amgen Stock-|Grant or research support-Celgene-|Grant or research support-Denovo-
Lynne V. Abruzzo, MD, PhD
Adjunct Professor of Pathology
The Ohio State University
Faculty
Nothing to disclose
Rodabe N. Amaria, MD
Associate Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Novartis AG-|Grant or research support-Merck and Company, Inc.-|Grant or research support-Bristol-Myers Squibb-|Grant or research support-Iovance-|Membership on advisory committees or review panels, board membership, etc.-Novartis AG-|Membership on advisory committees or review panels, board membership, etc.-Bristol-Myers Squibb-|Membership on advisory committees or review panels, board membership, etc.-Iovance-|Membership on advisory committees or review panels, board membership, etc.-Nektar-
Kenneth Bauer, MD, Physician
Professor
Beth Israel Deaconess Medical Center
Faculty
Nothing to disclose
Nancy Berliner, MD
Chief, Division of Hematology
Brigham and Women's Hospital
Faculty
Nothing to disclose
naifa L. busaidy, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Lauren A. Byers, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Advisor/Consultant and Research Funding, Oncology-AstraZeneca-|Advisor/Consultant and Research Funding, Oncology-GenMab-|Advisor/Consultant and Research Funding, Oncology-Sierra Oncology-|Grant or research support-ToleroPharmaceuticals-|Advisor/Consultant-Bristol-Myers Squibb-|Advisor/Consultant-Alethia-|Advisor/Consultant-Merck and Company, Inc.-|Advisor/Consultant-Pfizer, Inc.-|Advisor/Consultant-PharmaMar-|Advisor/Consultant-AbbVie-|Advisor/Consultant-Jazz Pharmaceuticals-|Advisor/Consultant-Genentech, Inc.-|Advisor/Consultant-Debiopharm Group-
Lisa Carey, MD
Deputy Director for Clinical Sciences
UNC-Lineberger Comprehensive Cancer Center
Faculty
Nothing to disclose
Tina Cascone, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center
Faculty
Paid consultant-AstraZeneca-|Paid consultant-Bristol-Myers Squibb-|Consulting Fee-Merck and Company, Inc.-|Honoraria-Roche-
Mariana C. Chavez MacGregor, MD, Profesor
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Membership on advisory committees or review panels, board membership, etc.-AstraZeneca-|Membership on advisory committees or review panels, board membership, etc.-Roche-|Membership on advisory committees or review panels, board membership, etc.-Pfizer, Inc.-|Membership on advisory committees or review panels, board membership, etc.-Exact Sciences-
Kelly S. Chien, MD
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Jorge Cortes, MD
Director
Georgia Cancer Center - Augusta University
Faculty
Grant or research support-Novartis AG-|Grant or research support-Takeda Pharmaceuticals, Inc.-|Grant or research support-Pfizer, Inc.-|Grant or research support-Sun Pharmaceuticals-|Consulting Fee-Novartis AG-|Consulting Fee-Takeda Pharmaceuticals, Inc.-|Consulting Fee-Pfizer, Inc.-|Consulting Fee-Sun Pharmaceuticals-
Daniel DeAngelo, MD

Faculty
Grant or research support-Abbvie, Novartis Blueprint, Glycomimetrics-|Paid consultant-Amgen, Agios, Autolus, Forty-Seven, Incyte, Jazz, Pfizer, Servier, Takeda-
Courtney D. DiNardo, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty
Membership on advisory committees or review panels, board membership, etc.-Agios -|Membership on advisory committees or review panels, board membership, etc.-Celgene-|Membership on advisory committees or review panels, board membership, etc.-Abbvie-|Stocks or stock options, excluding diversified mutual funds-Notable Labs-|Honoraria-Novartis AG-|Honoraria-Aprea-|Honoraria-Gilead-|Honoraria-Foghorn Therapeutics-
Nathan Fowler, MD
MD Anderson
Faculty
Membership on advisory committees or review panels, board membership, etc.-Roche-|Membership on advisory committees or review panels, board membership, etc.-Bristol-Myers Squib Aventis-|Membership on advisory committees or review panels, board membership, etc.-TG Therapuetics-|Membership on advisory committees or review panels, board membership, etc.-Gilead-
Ravin J. Garg, MD
Medical Doctor
Maryland Oncology Hematology/US Oncology and Assistant Professor of Oncology/Johns Hopkins Hospital
Faculty
Nothing to disclose
Timothy D. Gilligan, MD, FASCO, FACH
Associate Professor & Vice-Chair for Education
Cleveland Clinic Taussig Cancer Institute
Faculty
Nothing to disclose
Jahnavi Gollamudi, MD
Center for Translational Research on Inflammatory Diseases/ Baylor College of Medicine
Faculty
Nothing to disclose
Betty Hamilton, MD
Cleveland Clinic
Faculty
Membership on advisory committees or review panels, board membership, etc.-Syndax-|Membership on advisory committees or review panels, board membership, etc.-Equilium-
Nasser H. Hanna, MD
Professor of Medicine
Indiana University
Faculty
Grant or research support-Bristol-Myers Squibb-|Grant or research support-Genentech, Inc.-
Matthew Heeney, MD
Associate Chief - Hematology
Boston Children's Hospital
Faculty
Consulting Fee-AstraZeneca-|Consulting Fee-Novartis AG-|Paid consultant-Vertex/CRISPR-|Paid consultant-Keros Therapeutics-|Consulting Fee-Bluebird Bio-|Paid consultant-Cyclerion Therapeutics-|Paid consultant-FORMA Therapeutics-
Claudine Isaacs, MD, FRCPC
Professor
Georgetown
Faculty
Paid consultant-Pfizer, Inc.-|Paid consultant-AstraZeneca-|Paid consultant-Seattle Genetics-|Paid consultant-PUMA-|Paid consultant-Genentech, Inc.-|Paid consultant-Novartis AG-|Grant or research support-GlaxoSmithKline-
Eric Jonasch, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-Aravive-|Consulting Fee-Eisai, Inc.-|Consulting Fee-Exelixis-|Consulting Fee-Novartis AG-|Consulting Fee-Merck and Company, Inc.-|Consulting Fee-Pfizer, Inc.-|Grant or research support-Aravive-|Consulting Fee-NiKang Pharmaceuticals-|Grant or research support-Merck and Company, Inc.-|Grant or research support-Novartis AG-|Consulting Fee-Calithera-|Honoraria-Ipsen-
Scott Kopetz, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Consulting or Advisory Role-Roche-|Consulting or Advisory Role-Genentech, Inc.-|Consulting or Advisory Role-EMD Serono-|Consulting or Advisory Role-Merck and Company, Inc.-|Consulting or Advisory Role-Karyopharm Therapeutics-|Consulting or Advisory Role-Amal Therapeutics-|Consulting or Advisory Role-Navire Pharma-|Consulting or Advisory Role-Symphogen-|Consulting or Advisory Role-Holy Stone-|Consulting or Advisory Role-Biocartis-|Consulting or Advisory Role-Amgen-|Consulting or Advisory Role-Novartis AG-|Consulting or Advisory Role-Lilly-|Consulting or Advisory Role-Boehringer Ingelheim-|Consulting or Advisory Role-Boston Biomedical-|Consulting or Advisory Role-AstraZeneca/MedImmune-|Consulting or Advisory Role-Bayer Health-|Consulting or Advisory Role-Pierre Fabre-|Consulting or Advisory Role-Redx Pharma-
Mark Lewis, MD
Intermountain Healthcare
Faculty
Nothing to disclose
Whitney Lewis, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Jennifer K. Litton, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Pfizer, Inc.-|Grant or research support-EMD Serono-|Grant or research support-Genentech, Inc.-|Grant or research support-Zenith-|Grant or research support-AstraZeneca-|Speakers Bureau-Physicians Education Resource-|Speakers Bureau-MedLearning-|Speakers Bureau-Prime Oncology-|Speakers Bureau-Medscape-|Speakers Bureau-Clinical Care Options-|Speakers Bureau-Medpage-|Honoraria-San Antonio Breast Cancer Symposiuym-|Membership on advisory committees or review panels, board membership, etc.-ASCO-|Membership on advisory committees or review panels, board membership, etc.-NCCN-|Membership on advisory committees or review panels, board membership, etc.-SITC-|royalty-UptoDate-
Alice Ma, MD
Professor of Medicine
University of North Carolina
Faculty
Honoraria-Takeda Pharmaceuticals, Inc.-
Claire Mach, PharmD
Clinical Pharmacy Specialist
Harris Health System
Faculty
Nothing to disclose
Fernando Martinez, MD
Associate professor
MD Anderson
Faculty
Nothing to disclose
Nicholas Mitsiades, MD, PhD
University of California Davis Comprehensive Cancer Center
Faculty
Nothing to disclose
Stephan Moll, MD
UNC Chapel Hill
Faculty
Paid consultant-Pfizer, Inc.-|Honoraria-Stago Diagnostics-
Loretta J. Nastoupil, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-Bayer Corporation-|Honoraria-ADC Therapeutics-|Honoraria-Morphosys-|Honoraria-Epizyme-|Honoraria-Bristol-Myers Squibb-|Honoraria-Gilead-|Honoraria-Novartis AG-|Honoraria-Pfizer, Inc.-|Honoraria-Johnson and Johnson-|Grant or research support-Takeda Pharmaceuticals, Inc.-
Susan O'Brien, MD
Professor of Medicine
University of California Irvine
Faculty
Grant or research support-Kite-|Grant or research support-Regeneron-|Grant or research support-Acerta-|Grant or research support-Caribou-|Grant or research support-Gilead-|Grant or research support-Pharmacyclics-|Grant or research support-TG Therapeutics-
Timothy Olson, MD, PhD
Medical Director, Blood and Marrow Transplant Program
Children's Hospital of Philadelphia
Faculty
Paid consultant-Bluebird Bio-
Antonio Omuro, MD
Stanford University
Faculty
Consulting Fee-Ono Therapeutics-|Consulting Fee-Kiyatec-|Consulting Fee-Merck and Company, Inc.-
Brian Primeaux, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Barbara Pro, MD
Columbia University Irving Medical Center
Faculty
Honoraria-Takeda Pharmaceuticals, Inc.-|Honoraria-Seattle Genetics-
S. Vincent Rajkumar, MD
Professor of Medicine
Mayo Clinic
Faculty
Nothing to disclose
A. Koneti Rao, MD
Lewis Katz School of Medicine
Faculty
Nothing to disclose
Jose A. Rauh-Hain, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Alvin H. Schmaier, MD
Robert W. Kellermeyer Professor
CASE WESTERN RESERVE UNIVERSITY
Faculty
Grant or research support-Takeda Pharmaceuticals, Inc.-
Samuel A. Shelburne III, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Arlene O. Siefker-Radtke, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Membership on advisory committees or review panels, board membership, etc.-AstraZeneca-|Membership on advisory committees or review panels, board membership, etc.-Basilea Pharmaceutical LTD-|Paid consultant-Bavarian Nordic-|Paid consultant-Genentech, Inc.-|Paid consultant-Janssen-|Membership on advisory committees or review panels, board membership, etc.-Janssen-|Paid consultant-Merck Sharp & Dohme Corp-|Membership on advisory committees or review panels, board membership, etc.-Mirati Therapeutics-|Membership on advisory committees or review panels, board membership, etc.-Seattle Genetics, Inc.-|Paid consultant-Taiho Pharmaceutical Company, Inc.-|Paid consultant-Bristol-Myers Squibb-|Paid consultant-Immunomedics-|Membership on advisory committees or review panels, board membership, etc.-Ideaya Biosciences-|Grant or research support-Basilea Pharmaceutical LTD-|Grant or research support-Bristol-Myers Squibb-|Grant or research support-Merck-|Grant or research support-Nektar-|Grant or research support-Janssen-
Iberia Sosa, MD, PhD
Associate Professor, Chief Hematology
Fox Chase Cancer Center
Faculty
Membership on advisory committees or review panels, board membership, etc.-Pharmacosmos-
Srdan Verstovsek, MD, PhD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Shannon N. Westin, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-AstraZeneca-|Paid consultant-AstraZeneca-|Grant or research support-Clovis Oncology-|Paid consultant-Clovis Oncology-|Grant or research support-GlaxoSmithKline-|Paid consultant-GlaxoSmithKline-|Grant or research support-Genentech, Inc.-|Paid consultant-Genentech, Inc.-|Paid consultant-Roche-|Grant or research support-Novartis AG-|Paid consultant-Novartis AG-|Paid consultant-Merck and Company, Inc.-|Paid consultant-Agenus-|Paid consultant-Pfizer, Inc.-|Grant or research support-Bayer Corporation-|Grant or research support-Cotinga Pharmaceuticals-|Paid consultant-Zentalis-|Paid consultant-Eisai, Inc.-|Grant or research support-Mereo-
William N. William Jr., MD
Medical Oncologist
Hospital BP
Brazil
Faculty
Grant or research support-AstraZeneca-|Grant or research support-Merck and Company, Inc.-|Honoraria-Bristol-Myers Squibb-|Honoraria-Boehringer Ingelheim Vetmedica GmbH-|Honoraria-AstraZeneca-|Honoraria-Eli Lilly and Company-|Honoraria-F. Hoffmann La Roche Ltd.-|Honoraria-Johnson and Johnson-|Honoraria-Merck and Company, Inc.-|Honoraria-Novartis AG-|Honoraria-Pfizer, Inc.-|Honoraria-Sanofi-Aventis-|Honoraria-Takeda Pharmaceuticals, Inc.-
Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Harry H. Yoon, MD
Associate Professor
Mayo Clinic
Faculty
Grant or research support-Merck and Company, Inc.-|Grant or research support-Bristol-Myers Squibb-|Membership on advisory committees or review panels, board membership, etc.-ALX Oncology-|Membership on advisory committees or review panels, board membership, etc.-Oncxerna-|Membership on advisory committees or review panels, board membership, etc.-Zymeworks-|Membership on advisory committees or review panels, board membership, etc.-Astellas-|Membership on advisory committees or review panels, board membership, etc.-BeiGene-|Membership on advisory committees or review panels, board membership, etc.-Merck and Company, Inc.-|Membership on advisory committees or review panels, board membership, etc.-Bristol-Myers Squibb-|Membership on advisory committees or review panels, board membership, etc.-Macrogenics-|honoraria for education symposium-BeiGene-|Membership on advisory committees or review panels, board membership, etc.-AstraZeneca-
Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty, Planning Committee Member
Paid consultant-GlaxoSmithKline-|Paid consultant-Deciphera-|Paid consultant-Daiichi Sankyo-|Grant or research support-Hutchison MediPharma-|Grant or research support-Blueprint Medicines-
Nishin Bhadkamkar, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Planning Committee Member
Nothing to disclose
Felisha Estelle, BBA
CE Activity Planner
The University of Texas MD Anderson Cancer Center
Planning Committee Member
Nothing to disclose
Alessandra Ferrajoli, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center
Planning Committee Member
Membership on advisory committees or review panels, board membership, etc.-Other-BeiGene Inc.|Membership on advisory committees or review panels, board membership, etc.-AstraZeneca|Honoraria-Other-Janssen Corp.
Bonnie Glisson, MD
Professor
UT MD Anderson Cancer Center
Planning Committee Member
Nothing to disclose

Monday, September 27, 2021
Online Check in
6:45AM - 7:15AM
Welcome & Introduction
7:15AM - 7:30AM
 
BENIGN HEMATOLOGY SESSION: General Topics/Red Cell Disorders/Platelets

Iron Deficiency and Hemochromatosis
7:30AM - 8:15AM
Matthew Heeney, MD
Hematopoietic Growth Factors
8:15AM - 9:00AM
Martha Mims, MD, PhD
Bone Marrow Failure
9:00AM - 9:45AM
Timothy Olson, MD, PhD
Break
9:45AM - 10:00AM
Leukopenia and Leukocytosis
10:00AM - 10:45AM
Nancy Berliner, MD
Issues in Transfusion Medicine
10:45AM - 11:45AM
Fernando Martinez, MD
Q & A Panel Discussion
11:45AM - 12:00PM
Matthew Heeney, MD (Panelist)
Timothy Olson, MD, PhD (Panelist)
Martha Mims, MD, PhD (Panelist)
Nancy Berliner, MD (Panelist)
Fernando Martinez, MD (Panelist)
Lunch Break
12:00PM - 12:30PM
 
BENIGN HEMATOLOGY SESSION: Coagulation/Platelets/Red Cell Disorders

Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies
12:30PM - 1:15PM
Alice Ma, MD
Hemolytic Anemias
1:15PM - 2:00PM
Iberia Sosa, MD, PhD
Approach to Anemia
2:00PM - 2:30PM
Alice Ma, MD
Break
2:30PM - 2:45PM
Disorders of Platelet Function
2:45PM - 3:30PM
A. Koneti Rao, MD
Thrombocytopenias
3:30PM - 4:15PM
Alvin H. Schmaier, MD
Q & A Panel Discussion
4:15PM - 4:30PM
Alice Ma, MD (Panelist)
A. Koneti Rao, MD (Panelist)
Iberia Sosa, MD, PhD (Panelist)
Alvin H. Schmaier, MD (Panelist)
Adjourn
4:30PM - 4:31PM
Tuesday, September 28, 2021
 
BENIGN HEMATOLOGY SESSION: Platelet/Red Cell Disorders/Transfusion Medicine

Antithrombotic & Antiplatelet Therapy
7:30AM - 8:15AM
Alvin H. Schmaier, MD
Normal Coagulation
8:15AM - 9:00AM
Kenneth Bauer, MD, Physician
Break
9:00AM - 9:15AM
Coagulation Factor Deficiencies, Including von Willebrand's Disease and Hemophilias
9:15AM - 10:00AM
Kenneth Bauer, MD, Physician
Hypercoagulable States
10:00AM - 11:00AM
Stephan Moll, MD
Q & A Panel Discussion
11:00AM - 11:15AM
Kenneth Bauer, MD, Physician (Panelist)
Stephan Moll, MD (Panelist)
Alvin H. Schmaier, MD (Panelist)
Benign Hematology Q & A Session
11:15AM - 11:55AM
Jahnavi Gollamudi, MD
Lunch
11:55AM - 12:30PM
 
MALIGNANT HEMATOLOGY SESSION: Lymphoma/Leukemia

Classification of Lymphoma
12:30PM - 1:15PM
Lynne V. Abruzzo, MD, PhD
Aggressive Non-Hodgkin Lymphoma
1:15PM - 2:00PM
Loretta J. Nastoupil, MD
Break
2:00PM - 2:15PM
Indolent Non-Hodgkin Lymphoma
2:15PM - 3:00PM
Nathan Fowler, MD
Hodgkin Lymphoma
3:00PM - 3:45PM
Barbara Pro, MD
Acute Lymphoblastic Leukemia
3:45PM - 4:30PM
Daniel DeAngelo, MD
Q & A Panel Discussion
4:30PM - 4:45PM
Lynne V. Abruzzo, MD, PhD (Panelist)
Nathan Fowler, MD (Panelist)
Daniel DeAngelo, MD (Panelist)
Loretta J. Nastoupil, MD (Panelist)
Barbara Pro, MD (Panelist)
Adjourn
4:45PM - 4:46PM
Wednesday, September 29, 2021
 
MALIGNANT HEMATOLOGY SESSION: Myeloma/Leukemia/MDS

Multiple Myeloma and Other Plasma Cell Dyscrasias
7:30AM - 8:30AM
S. Vincent Rajkumar, MD
Chronic Lymphocytic Leukemia and Hairy Cell Leukemia
8:30AM - 9:15AM
Susan O'Brien, MD
Chronic Myeloid Leukemia
9:15AM - 10:00AM
Jorge Cortes, MD
Break
10:00AM - 10:15AM
Myelodysplastic Syndrome
10:15AM - 11:00AM
Tapan M. Kadia, MD
Acute Myeloid Leukemia
11:00AM - 11:45AM
Courtney D. DiNardo, MD
Q & A Panel Discussion
11:45AM - 12:00PM
Courtney D. DiNardo, MD (Panelist)
Jorge Cortes, MD (Panelist)
Susan O'Brien, MD (Panelist)
S. Vincent Rajkumar, MD (Panelist)
Tapan M. Kadia, MD (Panelist)
Malignant Hematology Q & A Session
12:00PM - 12:40PM
Kelly S. Chien, MD
Lunch Break
12:40PM - 1:15PM
 
MALIGNANT HEMATOLOGY SESSION: MPNs/Transplant/Infectious Disease

Myleoproliferative Neoplasms
1:15PM - 2:15PM
Srdan Verstovsek, MD, PhD
Stem Cell Transplant Supportive Care
2:15PM - 3:15PM
Betty Hamilton, MD
Break
3:15PM - 3:30PM
Infectious Complications in Cancer Patients
3:30PM - 4:15PM
Samuel A. Shelburne III, MD
Q & A Panel Discussion
4:15PM - 4:30PM
Srdan Verstovsek, MD, PhD (Panelist)
Betty Hamilton, MD (Panelist)
Samuel A. Shelburne III, MD (Panelist)
Adjourn
4:30PM - 4:31PM
Thursday, September 30, 2021
 
SOLID TUMOR SESSION: Pharmacology/Genetic Risk Factors/Neuro-Oncology

Pharmacology I: Chemotherapy
7:30AM - 8:30AM
Claire Mach, PharmD
Pharmacology II: Targeted Therapy (Alk, EGFR, VEGR, HER2, HH, mTOR, PARP)
8:30AM - 9:00AM
Whitney Lewis, PharmD
Pharmacology III: Targeted Therapy (CD20, CD30, CD33, Proteasome, BCR-ABL/KIT, FLT3, IDH1/2, CDK4/6, PI3K)
9:00AM - 9:30AM
Brian Primeaux, PharmD
Break
9:30AM - 9:45AM
Pharmacology IV: Immunotherapy
9:45AM - 10:05AM
Claire Mach, PharmD
Genetic Risk Factors
10:05AM - 10:50AM
Claudine Isaacs, MD, FRCPC
Neuro-Oncology
10:50AM - 11:35AM
Antonio Omuro, MD
Q & A Panel Discussion
11:35AM - 11:50AM
Brian Primeaux, PharmD (Panelist)
Whitney Lewis, PharmD (Panelist)
Claudine Isaacs, MD, FRCPC (Panelist)
Antonio Omuro, MD (Panelist)
Claire Mach, PharmD (Panelist)
Lunch Break
11:50AM - 12:15PM
 
SOLID TUMOR SESSION: Melanoma/Sarcoma/Gynecologic Oncology

Melanoma
12:15PM - 1:00PM
Rodabe N. Amaria, MD
Sarcoma
1:00PM - 2:00PM
Shreyaskumar Patel, MD
Cervical Cancer
2:00PM - 2:45PM
Jose A. Rauh-Hain, MD
Break
2:45PM - 3:00PM
Uterine Cancer
3:00PM - 3:30PM
Shannon N. Westin, MD
Ovarian Cancer and Unusual Ovarian Histologies
3:30PM - 4:30PM
Shannon N. Westin, MD
Q & A Panel Discussion
4:30PM - 4:45PM
Rodabe N. Amaria, MD (Panelist)
Shreyaskumar Patel, MD (Panelist)
Shannon N. Westin, MD (Panelist)
Jose A. Rauh-Hain, MD (Panelist)
Solid Tumor Q & A - Session 1: Pharmacology/Genetic Risk Factors/Neuro- Oncology/Melanoma/Sarcoma/GYN
4:45PM - 5:25PM
Mark Lewis, MD
Adjourn
5:25PM - 5:26PM
Friday, October 1, 2021
 
SOLID TUMOR SESSION: Breast Cancer

Screening/Local Management of Breast Cancer
7:30AM - 8:15AM
Jennifer K. Litton, MD
Systemic Treatment of Primary Breast Cancer Including HER2 Positive Breast Disease
8:15AM - 9:15AM
Lisa Carey, MD
Break
9:15AM - 9:30AM
Treatment of Metastatic Breast Cancer Including HER2 Positive Breast Disease
9:30AM - 10:30AM
Mariana C. Chavez MacGregor, MD, Profesor
Special Issues in Breast Cancer
10:30AM - 11:00AM
Sharon H. Giordano, MD, FASCO
Q & A Panel Discussion
11:00AM - 11:15AM
Mariana C. Chavez MacGregor, MD, Profesor (Panelist)
Jennifer K. Litton, MD (Panelist)
Lisa Carey, MD (Panelist)
Sharon H. Giordano, MD, FASCO (Panelist)
ASH/ASCO Choosing Wisely Recommendations
11:15AM - 11:55AM
Ravin J. Garg, MD
Lunch Break
11:55AM - 12:25PM
 
SOLID TUMOR SESSION: Lung Cancer/Head and Neck Cancer/Thyroid Cancer

Charles A. Koller, MD Lectureship Award
12:25PM - 12:30PM
Nasser H. Hanna, MD
Early Stage and Locally Advanced Non-Small Cell Lung Cancer
12:30PM - 1:15PM
Nasser H. Hanna, MD
Metastatic Non-Small Cell Lung Cancer
1:15PM - 2:15PM
Nasser H. Hanna, MD
Small Cell Lung Cancer
2:15PM - 2:45PM
Lauren A. Byers, MD
Break
2:45PM - 3:00PM
Head and Neck Cancer
3:00PM - 3:45PM
William N. William Jr., MD
Thyroid Cancer
3:45PM - 4:15PM
naifa L. busaidy, MD
Q & A Panel Discussion
4:15PM - 4:30PM
Nasser H. Hanna, MD (Panelist)
William N. William Jr., MD (Panelist)
Lauren A. Byers, MD (Panelist)
naifa L. busaidy, MD (Panelist)
Solid Tumor Q & A - Session 2: Breast Cancer/Lung Cancer/Head and Neck Cancer/Thyroid Cancer
4:30PM - 5:10PM
Tina Cascone, MD
Adjourn
5:10PM - 5:11PM
Saturday, October 2, 2021
 
SOLID TUMOR SESSION: Gastrointestinal Oncology

Pancreaticobiliary Cancers/Unknown Primary
7:30AM - 8:30AM
Robert A. Wolff, MD
Gastroesophageal Cancers/ Hepatocellular Carcinoma
8:30AM - 9:30AM
Harry H. Yoon, MD
Break
9:30AM - 9:45AM
Colorectal Cancer: Biology and Adjuvant Therapy
9:45AM - 10:15AM
Scott Kopetz, MD
Metastatic Colorectal Cancer and Anal Cancer
10:15AM - 11:15AM
Scott Kopetz, MD
Q & A Panel Discussion
11:15AM - 11:30AM
Scott Kopetz, MD (Panelist)
Robert A. Wolff, MD (Panelist)
Harry H. Yoon, MD (Panelist)
Lunch
11:30AM - 12:00PM
 
SOLID TUMOR SESSION: Genitourinary Oncology

Testicular Cancer
12:00PM - 1:00PM
Timothy D. Gilligan, MD, FASCO, FACH
Urothelial Cancer
1:00PM - 1:45PM
Arlene O. Siefker-Radtke, MD
Renal Cell Carcinoma
1:45PM - 2:30PM
Eric Jonasch, MD
Break
2:30PM - 2:45PM
Prostate Cancer
2:45PM - 4:00PM
Nicholas Mitsiades, MD, PhD
Q & A Panel Discussion
4:00PM - 4:15PM
Eric Jonasch, MD (Panelist)
Arlene O. Siefker-Radtke, MD (Panelist)
Nicholas Mitsiades, MD, PhD (Panelist)
Timothy D. Gilligan, MD, FASCO, FACH (Panelist)
Solid Tumor Q & A - Session 3: Gastrointestinal Oncology/Genitourinary Oncology
4:15PM - 4:55PM
Ravin J. Garg, MD
Adjourn
4:55PM - 5:00PM

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2026 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram